Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2000 Autumn;1(4):116-9.
doi: 10.1120/jacmp.v1i4.2632.

An investigation of eye lens dose for gamma knife treatments of trigeminal neuralgia

L Ma  1 , L Chin, M Sarfaraz, D Shepard, C Yu
Affiliations
Clinical Trial

An investigation of eye lens dose for gamma knife treatments of trigeminal neuralgia

L Ma et al. J Appl Clin Med Phys. 2000 Autumn.

Abstract

Stereotactic Gamma Knife radiosurgery has been widely used for treating trigeminal neuralgia (TN). A single large fractional dose of 7000 to 9000 cGy is commonly prescribed as the maximum dose for these treatments. For this reason, if a small percentage of the prescribed dose such as 2-3% scattered to the eye, it could reach or even exceed the tolerance dose of the lens. For several TN cases, we found that the Leksell Gamma Plan system calculates the lens dose about 0.5-2% of the maximum dose independent of the use of eye shielding. These dose values are significantly high and it motivated us to investigate the lens dose for the TN patients treated with stereotactic Gamma Knife radiosurgery. Phantom studies and in vivo dosimetry measurements were carried out for six patients treated at our institution. The average dose to the lens ipsilateral to the treated nerve was measured to be 7.7+/-0.6 cGy. Based on the biological model of Lyman and Emami [Int. J. Radiat. Oncol. Biol. Phys. 21, 109-122 (1991)], the probability of the lens complication (cataract) was determined to be 0.1%. Our findings suggest that few TN patients would develop cataracts after receiving Gamma Knife radiosurgery.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A special collimator shielding pattern used for treating trigeminal neuralgia patients at our institution.
Figure 2
Figure 2
(Color) Effects of the shielding pattern in on reducing the dose to the brain stem. (a) Dose distribution before the pattern is applied. (b) Dose distribution after the pattern is applied. Note that lower isodose lines as become tangential to the edge of the brain stem after the shielding being applied.
Figure 3
Figure 3
(Color) Experimental setup for the phantom studies.
Figure 4
Figure 4
Results of the in vivo dosimetry measurements for the TN patients.
See this image and copyright information in PMC

References

    1. Kondziolka D., Lunsford L. D., Habeck M., and Flickinger J. C., “Gamma Knife radiosurgery for trigeminal neuralgia,” Neurosurg. Clin. N. Am. 8(1), 79–85 (1997). - PubMed
    1. Benjamin W. C., Curran W. J. Jr., Shrieve D. C., and Loeffler J. S., “Stereotactic radiosurgery and radiotherapy: New developments and new directions,” Semin. Oncol. 24, 707–714 (1997). - PubMed
    1. Young R. R., Vermulen S., and Posewitz A., “Gamma Knife radiosurgery for the treatment of trigeminal neuralgia,” Stereotact. Funct Neurosurg. 70, Suppl 1, 192–199 (1998). - PubMed
    1. Emami B., Lyman J., Brown A., Coia L., Goiten M., Munzenrider J. E., Shank B., Solin L. J., and Wesson M.. “Tolerance of normal tissue to therapeutic radiation,” Int. J. Radiat. Oncol., Biol., Phys. 21, 109–122 (1991). - PubMed
    1. Rubin P., in The Law and Order of Radiation Sensitivity, Absolute and Relative in Radiation, edited by Vaeth J. M. and Meyer J. L. (Karger, Basel, Switzerland, 1989), Vol. 23. - PubMed

Publication types